Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have characterized expression of
beta-galactosidase
from a plasmid cloning vehicle, pBGP120, which carries most of the lacZ gene and contains a single EcoRI site near the end of lacZ. In addition, we have examined expression of heterologous DNA inserted at the position of the EcoRI site. The EcoRI site was shown to be within the sequence coding for
beta-galactosidase
and its precise location and phase were deduced. Insertion of heterologous EcoRI-generated DNA fragments altered the molecular weight of the plasmid-encoded
beta-galactosidase
polypeptide. Those insertions that were in the correct phase were expressed at a high level as a fused protein. The different forms of
beta-galactosidase
polypeptides produced by various hybrid plasmids were all stable proteins. The level of expression of the plasmid-encoded
beta-galactosidase
was several times higher than maximal expression of chromosome-encoded
beta-galactosidase
, suggesting that expression is proportional to gene copy number. The expression of the plasmid lacZ gene was controlled by cyclic AMP. When grown in a cya strain (DG74), expression was dependent on exogenous cyclic AMP. Although in normal strains there was insufficient lac repressor to inactivate all copies of the plasmid, repressor regulation was restored when the plasmid was grown in a strain (
M96
) that overproduces the lac repressor.
...
PMID:Regulated expression by readthrough translation from a plasmid-encoded beta-galactosidase. 20 72